These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of induction and maintenance chemotherapy in disseminated testicular non-seminomatous cancer. van Groeningen CJ; Stoter G Prog Clin Biol Res; 1984; 153():225-32. PubMed ID: 6206508 [No Abstract] [Full Text] [Related]
4. Lymphadenectomy for testicular carcinoma. Laplante MP; Mount BM Can J Surg; 1982 May; 25(3):262-6. PubMed ID: 6177391 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy is of value following retroperitoneal lymph node dissection for nonseminomatous testicular tumors. Scardino PT Urol Clin North Am; 1980 Oct; 7(3):735-45. PubMed ID: 6161463 [No Abstract] [Full Text] [Related]
7. [Combination chemotherapy of disseminated non-seminomatous testicular cancer. Combined with cis-diaminodichloroplatinum, vinblastine and bleomycin therapy]. Rørth M; Hansen M; Hansen HH; von der Maase H Ugeskr Laeger; 1980 Oct; 142(41):2691-3. PubMed ID: 6160668 [No Abstract] [Full Text] [Related]
8. The chemotherapy of testicular cancer. Drasga RE; Einhorn LH; Williams SD CA Cancer J Clin; 1982; 32(2):66-77. PubMed ID: 6174190 [No Abstract] [Full Text] [Related]
9. Chemotherapy of disseminated germinal tumors of the testis--comparison of vinblastine and bleomycin with vincristine, bleomycin, and actinomycin D. Spigel SC; Stephens RL; Haas CD; Jones HS; Lehane D; Moon TE; Coltman CA Cancer Treat Rep; 1978 Jan; 62(1):129-30. PubMed ID: 75064 [No Abstract] [Full Text] [Related]
10. Is adjuvant chemotherapy following retroperitoneal lymph node dissection for nonseminomatous testis cancer necessary? Donohue JP; Einhorn LH; Williams SD Urol Clin North Am; 1980 Oct; 7(3):747-56. PubMed ID: 6161464 [No Abstract] [Full Text] [Related]
11. Late relapse of nonseminomatous germ cell tumor of the testis: successful treatment with salvage chemotherapy alone. Papadimitris C; Papadimitriou C; Kokolakis N; Athanassiades P; Dimopoulos MA Urology; 1997 Mar; 49(3):469-70. PubMed ID: 9123720 [TBL] [Abstract][Full Text] [Related]
12. [Choriocarcinoma of the testis - tumor markers in chemotherapy]. Fliege R; Mann K; Hartenstein R; Löhrs U; Lamerz R Internist (Berl); 1981 Oct; 22(10):645-8. PubMed ID: 6170600 [No Abstract] [Full Text] [Related]
13. Vinblastine, cisplatin and bleomycin treatment of advanced nonseminomatous testicular tumors. Bodrogi I; Baki M; Horti J; Liszka G; Ottó S; Hindy I; Sugár J; Eckhardt S Neoplasma; 1990; 37(4):445-50. PubMed ID: 1700311 [TBL] [Abstract][Full Text] [Related]
14. Spontaneous pneumothorax as a result of intensive cytotoxic chemotherapy. Schulman P; Cheng E; Cvitkovic E; Golbey R Chest; 1979 Feb; 75(2):194-6. PubMed ID: 84731 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of testicular carcinomas. Monfardini S Anticancer Res; 1981; 1(6):309-12. PubMed ID: 6178356 [No Abstract] [Full Text] [Related]
16. Combination chemotherapy with cis-dichlorodiammineplatinum(II) and adriamycin for testicular cancer refractory to vinblastine plus bleomycin. Einhorn LH; Williams SD Cancer Treat Rep; 1978 Sep; 62(9):1351-3. PubMed ID: 80274 [No Abstract] [Full Text] [Related]